Related Experiment Videos
Hepatic angiosarcoma: long-term survival after complete surgical removal
C H Timaran1, O H Grandas, J L Bell
1Department of Surgery and Graduate School of Medicine, University of Tennessee Medical Center at Knoxville, USA.
The American Surgeon
|January 10, 2001
Summary
Hepatic angiosarcoma, a rare liver cancer, has a poor prognosis. Complete surgical resection, though rarely feasible, can lead to long-term survival, offering hope for patients with this aggressive tumor.
Area of Science:
- Hepatobiliary cancers
- Vascular oncology
- Diagnostic imaging in oncology
Background:
- Angiosarcoma of the liver is a rare primary liver tumor, accounting for 2% of all cases.
- This malignancy exhibits a link between environmental factors and malignant transformation.
- The prognosis for hepatic angiosarcoma is generally poor, with a median survival of approximately 6 months.
Observation:
- Computed tomography (CT) scans show nonspecific signs of hepatic angiosarcoma.
- Arteriography is identified as the optimal imaging modality for diagnosing this condition.
- Surgical resection of the liver is infrequently a viable option.
Findings:
- Complete surgical resection was achieved in a described case of hepatic angiosarcoma.
- This patient experienced a prolonged 10-year survival following complete surgical resection.
- The feasibility of hepatic resection depends on disease limitation and overall liver health.
Implications:
- Complete surgical resection, when possible, can significantly improve long-term outcomes for hepatic angiosarcoma patients.
- Early and accurate diagnosis using arteriography is crucial for treatment planning.
- Further research into environmental triggers and improved therapeutic strategies is warranted for this aggressive cancer.